(Q43212382)

16 November 2017

title

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

16 November 2017

main subject

0 references

author name string

Mo Yin Mok

1

1 reference

16 November 2017

Fang Ping Huang

2

1 reference

16 November 2017

Wai Ki Ip

3

1 reference

16 November 2017

Yi Lo

4

1 reference

16 November 2017

Fung Yi Wong

5

1 reference

16 November 2017

Eric Yuk Tat Chan

6

1 reference

16 November 2017

Kwok Fai Lam

7

1 reference

16 November 2017

Damo Xu

8

1 reference

16 November 2017

language of work or name

1 reference

21 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

49

1 reference

16 November 2017

issue

3

1 reference

16 November 2017

page(s)

520-527

1 reference

IL-33 exacerbates antigen-induced arthritis by activating mast cells

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

IL-33 is a chemoattractant for human Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Type I interferons inhibition of inflammatory T helper cell responses in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

The IL-33/ST2 pathway: therapeutic target and novel biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

T1/ST2--an IL-1 receptor-like modulator of immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

Expression and function of the ST2 gene in a murine model of allergic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEP402

10.1093/RHEUMATOLOGY/KEP402

21 January 2018

Identifiers

DOI

1 reference

16 November 2017

1 reference